UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 243

Sortiert nach

The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis

PloS one, 2014-07, Vol.9 (7), p.e101554-e101554

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study

Journal of hepatology, 2020-08, Vol.73 (2), p.277-284

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of hepatitis C virus treatment on the risk of non‐hepatic cancers among hepatitis C virus‐infected patients in the US

Alimentary pharmacology & therapeutics, 2020-11, Vol.52 (10), p.1592-1602

2020

Link zum Volltext

Verfügbarkeit prüfen

Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients

JAMA : the journal of the American Medical Association, 2022-08, Vol.328 (7), p.637

2022

Link zum Volltext

Verfügbarkeit prüfen

The short‐term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct‐acting antivirals: An ERCHIVES study

Hepatology (Baltimore, Md.), 2018-06, Vol.67 (6), p.2244-2253

2018

Link zum Volltext

Verfügbarkeit prüfen

Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medications

Journal of the American Geriatrics Society (JAGS), 2023-06, Vol.71 (6), p.1861-1872

2023

Link zum Volltext

Verfügbarkeit prüfen

Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals

Journal of general internal medicine : JGIM, 2020-07, Vol.35 (7), p.2025-2034

2020

Link zum Volltext

Verfügbarkeit prüfen

Liver fibrosis progression in hepatitis C virus infection after seroconversion

JAMA internal medicine, 2015-02, Vol.175 (2), p.178

2015

Link zum Volltext

Verfügbarkeit prüfen

Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real‐world healthcare databases

Pharmacoepidemiology and drug safety, 2023-01, Vol.32 (1), p.1-8

2023

Link zum Volltext

Verfügbarkeit prüfen

A SEMIPARAMETRIC MODELING APPROACH USING BAYESIAN ADDITIVE REGRESSION TREES WITH AN APPLICATION TO EVALUATE HETEROGENEOUS TREATMENT EFFECTS

The annals of applied statistics, 2019-09, Vol.13 (3), p.1989-2010

2019

Link zum Volltext

Verfügbarkeit prüfen

HCV epidemiology in high-risk groups and the risk of reinfection

Journal of hepatology, 2016-10, Vol.65 (1), p.S33-S45

2016

Link zum Volltext

Verfügbarkeit prüfen

Profiling real‐world data sources for pharmacoepidemiologic research: A call for papers

Pharmacoepidemiology and drug safety, 2022-09, Vol.31 (9), p.929-931

2022

Link zum Volltext

Verfügbarkeit prüfen

Is Moderate Alcohol Consumption Safe for Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Women?

Clinical infectious diseases, 2017-12, Vol.65 (12), p.2057-2059

Re, Vincent Lo

2017

Link zum Volltext

Verfügbarkeit prüfen

Drug‐Drug Interaction Surveillance Study: Comparing Self‐Controlled Designs in Five Empirical Examples in Real‐World Data

Clinical pharmacology and therapeutics, 2021-05, Vol.109 (5), p.1353-1360

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVES

Clinical infectious diseases, 2017-07, Vol.65 (1), p.64-72

2017

Link zum Volltext

Verfügbarkeit prüfen

Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection

PloS one, 2020-02, Vol.15 (2), p.e0228471-e0228471

2020

Link zum Volltext

Verfügbarkeit prüfen

Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV‐Positive and HIV‐Negative Individuals in VACS (Veterans Aging Cohort Study)

Journal of the American Heart Association, 2018-05, Vol.7 (10), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status

The American journal of medicine, 2016-03, Vol.129 (3), p.283-291.e5

2016

Link zum Volltext

Verfügbarkeit prüfen

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study

Annals of internal medicine, 2014-03, Vol.160 (6), p.369

2014

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus–Infected, and Uninfected Patients

Clinical infectious diseases, 2014-05, Vol.58 (10), p.1449-1458

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk of hip fracture associated with hepatitis c virus infection and hepatitis C/human immunodeficiency virus coinfection

Hepatology (Baltimore, Md.), 2012-11, Vol.56 (5), p.1688-1698

2012

Link zum Volltext

Verfügbarkeit prüfen

Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance

Clinical gastroenterology and hepatology, 2016-07, Vol.14 (7), p.1035-1043

2016

Link zum Volltext

Verfügbarkeit prüfen

Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional Incentives

Arthritis & rheumatology (Hoboken, N.J.), 2020-07, Vol.72 (7), p.1067-1071

2020

Link zum Volltext

Verfügbarkeit prüfen

Oral health outcomes in an HIV cohort with comorbidities- implementation roadmap for a longitudinal prospective observational study

BMC oral health, 2023-10, Vol.23 (1), p.763-763, Article 763

2023

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients-Reply

JAMA : the journal of the American Medical Association, 2022-12, Vol.328 (24), p.2458

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(159)
Life Sciences & Biomedicine
(153)
Humans
(133)
Male
(91)
Female
(88)
Middle Aged
(80)
Infectious Diseases
(69)
Hiv
(64)
Adult
(57)
Human Immunodeficiency Virus
(47)
Hepatitis C
(45)
Hiv Infections - Complications
(44)
Risk Factors
(38)
Immunology
(36)
Retrospective Studies
(36)
Hepatitis
(34)
Public, Environmental & Occupational Health
(34)
Cohort Studies
(33)
Aged
(31)
Pharmacology & Pharmacy
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis

Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study

Impact of hepatitis C virus treatment on the risk of non‐hepatic cancers among hepatitis C virus‐infected patients in the US

Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients

The short‐term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct‐acting antivirals: An ERCHIVES study

Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medications

Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals

Liver fibrosis progression in hepatitis C virus infection after seroconversion

Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real‐world healthcare databases

A SEMIPARAMETRIC MODELING APPROACH USING BAYESIAN ADDITIVE REGRESSION TREES WITH AN APPLICATION TO EVALUATE HETEROGENEOUS TREATMENT EFFECTS

HCV epidemiology in high-risk groups and the risk of reinfection

Profiling real‐world data sources for pharmacoepidemiologic research: A call for papers

Is Moderate Alcohol Consumption Safe for Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Women?

Drug‐Drug Interaction Surveillance Study: Comparing Self‐Controlled Designs in Five Empirical Examples in Real‐World Data

Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVES

Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection

Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV‐Positive and HIV‐Negative Individuals in VACS (Veterans Aging Cohort Study)

Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study

Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus–Infected, and Uninfected Patients

Risk of hip fracture associated with hepatitis c virus infection and hepatitis C/human immunodeficiency virus coinfection

Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance

Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional Incentives

Oral health outcomes in an HIV cohort with comorbidities- implementation roadmap for a longitudinal prospective observational study

COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients-Reply

Suchergebnisse filtern